Huan Liu1,2,3, Ronghua Zhao1, Rongrong Qin1, Haoyu Sun2,3, Qiang Huang1, Lianxin Liu1, Zhigang Tian2,3, Björn Nashan1, Cheng Sun1,2,3, Rui Sun2,3. 1. The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, China. 2. The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230027, China. 3. Institute of Immunology, University of Science and Technology of China, Hefei 230027, China.
Abstract
OBJECTIVE: NK cells play crucial roles in the immune defense mechanisms against viral infections and transformed cells. However, the developmental progression, transcriptomic landscape, and functional subtypes of liver NK cells are not well defined. Hepatocellular carcinoma (HCC) accounts for approximately 80% of primary liver cancer worldwide, yet the biological characteristics of NK cells in the HCC environment are unclear. Therefore, we aimed to determine these cells' roles in tumorigenesis and prognosis. METHODS: We compared the single-cell RNA sequencing profiles of NK cells purified from blood (n = 1), healthy liver tissues (n = 3), HCC tumor tissues (n = 4), and peritumor liver tissues (n = 1) to identify NK cell subsets. Furthermore, we performed bioinformatics analysis by using The Cancer Genome Atlas (TCGA) data to identify prognostic biomarkers simultaneously overexpressed in the blood and tumor tissues of patients with HCC. RESULTS: Transcriptomic analysis revealed 5 NK cell subsets (L1-NK-CD56bright, L2-NK-CD56dim, L3-NK-HLA, L4-LrNK-FCGR3A, and L5-LrNK-XCL1) in the healthy liver tissues. However, the transitional L3 subset and the CXCR6+CD16+ L4 subset with strong anti-tumor activity were absent in the HCC and peritumor liver tissues. Furthermore, 4 common prognosis-associated genes (RHOB, TALDO1, HLA-DPA1, and TKT) were significantly overexpressed in the paired tumor tissue and blood. CONCLUSIONS: Our study revealed 5 specific subsets of NK cells in healthy human liver tissues. However, only 3 of the 5 NK cell subsets were present in HCC and peritumor tissues. The cytotoxic NK cell subsets were absent in HCC tissues. Furthermore, we identified 4 potential non-invasive prognostic biomarkers in patients with HCC.
OBJECTIVE: NK cells play crucial roles in the immune defense mechanisms against viral infections and transformed cells. However, the developmental progression, transcriptomic landscape, and functional subtypes of liver NK cells are not well defined. Hepatocellular carcinoma (HCC) accounts for approximately 80% of primary liver cancer worldwide, yet the biological characteristics of NK cells in the HCC environment are unclear. Therefore, we aimed to determine these cells' roles in tumorigenesis and prognosis. METHODS: We compared the single-cell RNA sequencing profiles of NK cells purified from blood (n = 1), healthy liver tissues (n = 3), HCC tumor tissues (n = 4), and peritumor liver tissues (n = 1) to identify NK cell subsets. Furthermore, we performed bioinformatics analysis by using The Cancer Genome Atlas (TCGA) data to identify prognostic biomarkers simultaneously overexpressed in the blood and tumor tissues of patients with HCC. RESULTS: Transcriptomic analysis revealed 5 NK cell subsets (L1-NK-CD56bright, L2-NK-CD56dim, L3-NK-HLA, L4-LrNK-FCGR3A, and L5-LrNK-XCL1) in the healthy liver tissues. However, the transitional L3 subset and the CXCR6+CD16+ L4 subset with strong anti-tumor activity were absent in the HCC and peritumor liver tissues. Furthermore, 4 common prognosis-associated genes (RHOB, TALDO1, HLA-DPA1, and TKT) were significantly overexpressed in the paired tumor tissue and blood. CONCLUSIONS: Our study revealed 5 specific subsets of NK cells in healthy human liver tissues. However, only 3 of the 5 NK cell subsets were present in HCC and peritumor tissues. The cytotoxic NK cell subsets were absent in HCC tissues. Furthermore, we identified 4 potential non-invasive prognostic biomarkers in patients with HCC.
Authors: D G Doherty; S Norris; L Madrigal-Estebas; G McEntee; O Traynor; J E Hegarty; C O'Farrelly Journal: J Immunol Date: 1999-08-15 Impact factor: 5.422
Authors: Kelly Hudspeth; Matteo Donadon; Matteo Cimino; Elena Pontarini; Paolo Tentorio; Max Preti; Michelle Hong; Antonio Bertoletti; Silvio Bicciato; Pietro Invernizzi; Enrico Lugli; Guido Torzilli; M Eric Gershwin; Domenico Mavilio Journal: J Autoimmun Date: 2015-08-30 Impact factor: 7.094
Authors: Luca Mazzurana; Paulo Czarnewski; Viktor Jonsson; Leif Wigge; Markus Ringnér; Teresa C Williams; Avinash Ravindran; Åsa K Björklund; Jesper Säfholm; Gunnar Nilsson; Sven-Erik Dahlén; Ann-Charlotte Orre; Mamdoh Al-Ameri; Charlotte Höög; Charlotte Hedin; Sylwester Szczegielniak; Sven Almer; Jenny Mjösberg Journal: Cell Res Date: 2021-01-08 Impact factor: 46.297